Integration of fragment screening and library design

Area of Science:

• Drug discovery and development
• Biophysics
• Medicinal chemistry

Background:

• Fragment-based drug discovery (FBDD) has matured over a decade, becoming a key strategy in pharmaceutical and biotechnology industries.
• Various biophysical techniques are employed to detect weak interactions between small molecule fragments and biological targets.
• The choice of screening technology and fragment library design is often dictated by the specific requirements of the target molecule.

Purpose of the Study:

• To highlight the importance of target-centric optimization in fragment-based drug discovery.
• To discuss the current state and future challenges of FBDD, particularly for targets lacking high-resolution structural information.
• To provide a roadmap for fragment-to-lead evolution using available structural data.

Main Methods:

• Review of established biophysical techniques used in FBDD.
• Analysis of the relationship between target properties, fragment library design, and screening methodologies.
• Examination of existing strategies for fragment-to-lead optimization.

Main Results:

• FBDD is a validated and mainstream drug discovery paradigm.
• Target characteristics should guide the development of both fragment libraries and screening technologies for optimal FBDD outcomes.
• A clear pathway exists for fragment-to-lead progression when target structural information is available.

Conclusions:

• The strategic alignment of fragment libraries and screening methods with target properties is crucial for maximizing FBDD efficiency.
• Future FBDD efforts must address the challenge of discovering drugs for targets where high-resolution structural data is not obtainable.
• Continued innovation in screening technologies and library design will be essential for expanding the applicability of FBDD.